A Virtual-First Telehealth Treatment Model for Opioid Use Disorder
- 1 December 2022
- journal article
- letter
- Published by Springer Science and Business Media LLC in Journal of General Internal Medicine
- Vol. 38 (3), 814-816
- https://doi.org/10.1007/s11606-022-07955-x
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use DisorderAmerican Journal of Psychiatry, 2020
- Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrolleesJournal of Substance Abuse Treatment, 2018
- Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured populationJournal of Substance Abuse Treatment, 2017